Editorial Board About Us

Prostatic neoplasms

All articles from this key word are listed below.

Volume 2, Supplement 4 Supplement

Epidemiology and Screening

Prostate Cancer:

Michael Fowler Fritz H Schroeder Scott M Lucia Michael K Brawer E David Crawford

Prostatic neoplasms Prostate-specific antigen Prostatectomy Prognosis Neoplasm staging

Volume 2, Supplement 4 Supplement

Serum and Tissue Markers for Prostate Cancer

Serum and Tissue Markers for Prostate Cancer

Nelson Neal Stone Hans Lilja Martin E Gleave Martin I Resnick Michael K Brawer

Prostatic neoplasms Prostate-specific antigen Tumor markers Sensitivity and specificity

Volume 2, Supplement 4 Supplement

New Horizons in the Management of Hormone-Refractory Prostate Cancer

New Horizons in the Management of Hormone-Refractory Prostate Cancer

Prostatic neoplasms Prostate-specific antigen Androgen antagonists Antineoplastic agents Palliative care

Volume 4, Supplement 5 Supplement

Risk Factors for Prostate Cancer

Prostatic neoplasms Risk factors Epidemiology

Volume 7, Number 1 Point-Counterpoint

Laproscopic Radical Prostatectomy in Obese Patients: Feasible or Foolhardy?

Prostatic neoplasms Obesity Laparoscopy Prostatectomy

Volume 11, Number 4 Review Articles

Focal Therapy: A New Paradigm for the Treatment of Prostate Cancer

Treatment Update

Guilherme Godoy Basir Tareen Samir S Taneja

Focal therapy has been proposed in recent years as a means of bridging the gap between radical prostatectomy and active surveillance for treatment of prostate cancer. The rationale for focal therapy comes from its success in treating other malignancies. One of the challenges in applying such an approach to the treatment of prostate cancer has been the multifocal nature of the disease. This review addresses the selection of potentially ideal candidates for focal therapy and discusses which modalities are currently being used and proposed for focal therapy. Setting and meeting guidelines for oncologic efficacy is a challenge we must embrace to safely deliver this potentially revolutionary approach to treating men with prostate cancer.[Rev Urol. 2009;11(4):203-212 doi: 10.3909/riu0475]© 2009 MedReviews®, LLC

Prostatic neoplasms Focal therapy Prostate-specific antigen Prostatectomy Photodynamic therapy Ultrasound, high-inten sity focused, transrectal Cryosurgery

Volume 12, Number 1 Review Articles

Open Versus Laparoscopic Versus Robot-Assisted Laparoscopic Prostatectomy: The European and US Experience

Treatment Update

Elisabeth Eckersberger Helen Sadri Julia Finkelstein Bob Djavan Samir S Taneja Herbert Lepor

Open radical prostatectomy (ORP) is the reference standard for the surgical management of localized prostate cancer. With wider availability of minimally invasive radical prostatectomy techniques, there is a debate regarding the standard treatment of the management of localized prostate cancer. Therefore, we reviewed the current status of laparoscopic radical prostatectomy (LRP) and robotic-assisted laparoscopic radical prostatectomy (RALRP) as compared with ORP. Because no prospective, randomized trials comparing the different techniques have been performed, outcomes must be assessed from published series by centers that focus on ORP, LRP, and RALRP. Aside from reducing the amount of blood loss, current data suggest that the most significant outcomes (cure, continence, and potency) are no better with LRP or RALRP than with conventional ORP. Therefore, in experienced hands, ORP remains the gold standard procedure. However, there is a trend toward consistently better outcomes following RALRP in comparison with LRP. In the end, individual patient outcomes can be maximized by choosing the best modality based on the patient’s comorbid medical conditions, cancer characteristics, and surgeon experience. Future studies are needed to further investigate long-term cancer control as well as functional outcomes for RALRP series.[Rev Urol. 2010;12(1):35-43 doi: 10.3909/riu0470]

Prostatic neoplasms Laparoscopy Prostatectomy Robotics

Volume 22, Number 2 Review Articles

The Role of Multiparametric MRI and MRI-targeted Biopsy in Detecting Clinically Significant Prostate Cancer in the Community Setting: A Retrospective Study

Original Research

Kenneth E Schmanke Fadi N Joudi Matthew P Lierz Serge G Srour Rosalee E Zackula Jordan J Stiverson

Multiparametric MRI and the Prostate Imaging-Reporting and Data System (PI-RADS) have emerged as tools to reveal suspicious prostate lesions and MRI-targeted biopsy has shown potential to avoid repeat prostate biopsies and miss fewer significant cancers. This retrospective study sought to assess the differences in diagnostic yield and sampling efficiency between MRI-targeted and standard biopsies in a community urology practice. We concluded that MRI-targeted biopsy was more efficient than a standard biopsy, although neither technique achieved a superior diagnostic yield of clinically significant cancer in our community setting. We recommend that a standard biopsy be performed alongside targeted biopsy. [Rev Urol. 2020;22(2):57–66] © 2020 MedReviews®, LLC

Health services research Prostatic neoplasms Image-guided biopsy Multiparametric MRI Ambulatory care facilities